AliveCor and Thomas Jefferson University Hospital Partner to Evaluate KardiaMobile 6L for QT Prolongation Screening in Patients Treated for Opioid Use Disorder

Pilot study will assess positive impacts of real-time safety monitoring on patient outcomes and treatment experience MOUNTAIN VIEW, Calif., July 20, 2023 /PRNewswire/ — AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced a…

Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks